Blocking Herpes Simplex Virus 2 Glycoprotein E Immune Evasion as an Approach to Enhance Efficacy of a Trivalent Subunit Antigen Vaccine for Genital Herpes

Journal of Virology - United States
doi 10.1128/jvi.01130-14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Immune Evasion by Herpes Simplex Viruses

2016English

Oncolytic Herpes Simplex Virus ICP47 Deletion Reverses Tumor Immune Evasion

Yangtze Medicine
2018English

Herpes Simplex Virus Glycoproteins as Treatment for Recurrent Genital Herpetic Infection

Pediatric Research
Child HealthPediatricsPerinatology
1987English

Genital Herpes Simplex Virus Type 1 in Women.

Sexually Transmitted Infections
DermatologyInfectious Diseases
1994English

Vaccine-Induced Serum Immunoglobin Contributes to Protection From Herpes Simplex Virus Type 2 Genital Infection in the Presence of Immune T Cells

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

Herpes Simplex Virus Type 1 Targets the MHC Class II Processing Pathway for Immune Evasion

Journal of Immunology
AllergyImmunology
2003English

Secreted Portion of Glycoprotein G of Herpes Simplex Virus Type 2 Is a Novel Antigen for Type-Discriminating Serology

Journal of Clinical Microbiology
Microbiology
2003English

Apolipoprotein E and Herpes Virus Diseases: Herpes Simplex Keratitis

European Journal of Human Genetics
Genetics
1999English

A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection Against HSV-1 and HSV-2 Genital Infections

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy